Conversation with The Cancer Letter Rick Klausner: This is a profoundly disturbing statement about dramatically de-prioritizing research, science, and biomedical research March 24, 2017Vol.43 No.12By Paul Goldberg
Drugs & Targets NICE recommends Vectibix for previously untreated metastatic colorectal cancer March 10, 2017Vol.43 No.10
Drugs & Targets EnGeneIC receives Orphan designation for its technology in glioblastoma multiforme March 10, 2017Vol.43 No.10
Drugs & Targets German Community of Gynecological Oncology acknowledges MammaPrint as having Level 1A clinical evidence March 10, 2017Vol.43 No.10
In Brief NCCN “Just Bag It!” campaign shoots for 100 new adopters by end of conference March 10, 2017Vol.43 No.10
In Brief Targeted Anticancer Therapies Congress becomes an annual ESMO Event March 10, 2017Vol.43 No.10
In Brief ASCO and ONS launch collaboration to advance engagement in CancerLinQ March 10, 2017Vol.43 No.10
